Accuracy and Precision Analysis for a Biophotonic Assay of C-Reactive Protein
James-Pemberton, P; Lapinska, U; Helliwell, M; et al.Olkhov, RV; Hedaux, OJ; Hyde, CJ; Shaw, AM
Date: 18 February 2020
Journal
Analyst
Publisher
Royal Society of Chemistry
Publisher DOI
Abstract
A multiplexed biophotonic assay platform has been developed using the localised particle
plasmon in gold nanoparticles assembled in an array and functionalised for two assays: total
IgG and C-reactive protein (CRP). A protein A/G (PAG) assay, calibrated with a NIST
reference material, shows a maximum surface coverage of max = 7.13 ...
A multiplexed biophotonic assay platform has been developed using the localised particle
plasmon in gold nanoparticles assembled in an array and functionalised for two assays: total
IgG and C-reactive protein (CRP). A protein A/G (PAG) assay, calibrated with a NIST
reference material, shows a maximum surface coverage of max = 7.13 ± 0.19 mRIU,
equivalent to 1.5 ng mm-2 of F(ab)-presenting antibody. The CRP capture antibody has an
equivalent surface binding density of max = 2.95 ± 0.41 mRIU indicating a 41% capture
antibody availability. Free PAG binding to the functionalised anti-CRP surface shows that
only 47 ± 3 % of CRP capture antibodies are correctly presenting Fab regions for antigen
capture. The accuracy and precision of the CRP sensor assay was assessed with 54 blood
samples containing spiked CRP in the range 2 – 160 mg/L. The mean accuracy was 0.42 mg/L
with Confidence Interval (CI) at 95% from -14.7 to 13.8 mg/L and the precision had a
Coefficient of Variation (CV) of 10.6% with 95% CI 0.9% - 20.2%. These biophotonic platform
performance metrics indicate a CRP assay with 2 - 160 mg/L dynamic range, performed in 8
minutes from 5 L of whole blood without sample preparation.
Biosciences - old structure
Collections of Former Colleges
Item views 0
Full item downloads 0